Understanding the cytokine/chemokine networks in CD4؉ and CD8 ؉ T cells during the acute phase of infection is crucial to design therapies for the control of early human immunodeficiency virus ( ؉ and CD8 ؉ T cells, upregulation of -chemokines, fibroblast growth factor-basic, hepatocyte growth factor, and migration inhibition factor may provide a poor prognosis.
and CD8 ؉ T cells, upregulation of -chemokines (CCL2 and CCL22), basic fibroblast growth factor (FGF-basic), hepatocyte growth factor (HGF), and migration inhibition factor (MIF) may provide a poor prognosis either by inducing increased virus replication or by other unknown mechanisms. Therefore, drugs targeting -chemokines (CCL2 and CCL22), FGF-basic, HGF, or MIF might be important for developing effective vaccines and therapeutics against HIV.
IMPORTANCE
Human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection results in early depletion of CD4